BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33012736)

  • 1. Risk Factors for Major Bleeding During Anticoagulation Therapy in Cancer-Associated Venous Thromboembolism - From the COMMAND VTE Registry.
    Nishimoto Y; Yamashita Y; Kim K; Morimoto T; Saga S; Amano H; Takase T; Hiramori S; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Sato Y; Kimura T;
    Circ J; 2020 Oct; 84(11):2006-2014. PubMed ID: 33012736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for Major Bleeding during Prolonged Anticoagulation Therapy in Patients with Venous Thromboembolism: From the COMMAND VTE Registry.
    Kim K; Yamashita Y; Morimoto T; Kitai T; Yamane T; Ehara N; Kinoshita M; Kaji S; Amano H; Takase T; Hiramori S; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Furukawa Y; Kimura T;
    Thromb Haemost; 2019 Sep; 119(9):1498-1507. PubMed ID: 31230344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors of thrombotic recurrence and major bleeding in patients with intermediate-risk for recurrence of venous thromboembolism.
    Yamashita Y; Amano H; Morimoto T; Kadota K; Hata R; Matsushita K; Osakada K; Sano A; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Inoko M; Tada T; Chen PM; Murata K; Tsuyuki Y; Nishimoto Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Kato T; Ono K; Kimura T;
    J Thromb Thrombolysis; 2022 Jan; 53(1):182-190. PubMed ID: 34228248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation Therapy for Venous Thromboembolism in the Real World - From the COMMAND VTE Registry.
    Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Konishi T; Akao M; Kobayashi Y; Inoue T; Oi M; Izumi T; Takahashi K; Tada T; Chen PM; Murata K; Tsuyuki Y; Sakai H; Saga S; Sasa T; Sakamoto J; Yamada C; Kinoshita M; Togi K; Ikeda T; Ishii K; Kaneda K; Mabuchi H; Otani H; Takabayashi K; Takahashi M; Shiomi H; Makiyama T; Ono K; Kimura T;
    Circ J; 2018 Apr; 82(5):1262-1270. PubMed ID: 29576597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transition of management strategies and long-term outcomes in cancer-associated venous thromboembolism from the warfarin era to the direct oral anticoagulant era.
    Chatani R; Yamashita Y; Morimoto T; Kaneda K; Mushiake K; Kadota K; Nishimoto Y; Ikeda N; Kobayashi Y; Ikeda S; Kim K; Inoko M; Takase T; Tsuji S; Oi M; Kimura T;
    Eur J Intern Med; 2024 May; 123():72-80. PubMed ID: 38278660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the VTE-BLEED score's long-term performance for major bleeding in patients with venous thromboembolisms: From the COMMAND VTE registry.
    Nishimoto Y; Yamashita Y; Morimoto T; Saga S; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Sato Y; Kimura T;
    J Thromb Haemost; 2020 Mar; 18(3):624-632. PubMed ID: 31785073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age and long-term outcomes of patients with venous thromboembolism: From the COMMAND VTE Registry.
    Takahashi K; Yamashita Y; Morimoto T; Tada T; Sakamoto H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Chen PM; Murata K; Tsuyuki Y; Nishimoto Y; Sakamoto J; Togi K; Mabuchi H; Takabayashi K; Kato T; Ono K; Kimura T;
    Int J Cardiol; 2023 Jul; 383():89-95. PubMed ID: 37156304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periprocedural management and clinical outcomes of invasive procedures after venous thromboembolism: from the COMMAND VTE registry.
    Hata R; Yamashita Y; Morimoto T; Kadota K; Amano H; Murai R; Osakada K; Sano A; Takase T; Hiramori S; Kim K; Oi M; Akao M; Doi K; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Nishimoto Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Tsujisaka Y; Seko Y; Matsushita K; Yoneda F; Kato T; Ono K; Kimura T;
    J Thromb Thrombolysis; 2022 Feb; 53(2):540-549. PubMed ID: 34524599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation strategies and clinical outcomes after bleeding events during anticoagulation therapy for venous thromboembolism in the practice-based Japanese registry.
    Yamashita Y; Morimoto T; Klok FA; Barco S; Nishimoto Y; Kato T; Ono K; Kimura T;
    J Thromb Thrombolysis; 2022 Oct; 54(3):524-534. PubMed ID: 35713842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated venous thromboembolism in the direct oral anticoagulants era: Insight from the COMMAND VTE Registry-2.
    Chatani R; Yamashita Y; Morimoto T; Mushiake K; Kadota K; Kaneda K; Nishimoto Y; Ikeda N; Kobayashi Y; Ikeda S; Kim K; Inoko M; Takase T; Tsuji S; Oi M; Takada T; Otsui K; Sakamoto J; Ogihara Y; Inoue T; Usami S; Chen PM; Togi K; Koitabashi N; Hiramori S; Doi K; Mabuchi H; Tsuyuki Y; Murata K; Takabayashi K; Nakai H; Sueta D; Shioyama W; Dohke T; Nishikawa R; Kimura T;
    Thromb Res; 2024 Feb; 234():86-93. PubMed ID: 38190788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-Associated Venous Thromboembolism in the Real World - From the COMMAND VTE Registry.
    Sakamoto J; Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Nishimoto Y; Sasa T; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Tamura T; Nakagawa Y; Kimura T;
    Circ J; 2019 Oct; 83(11):2271-2281. PubMed ID: 31548438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation strategies and long-term recurrence in patients with venous thromboembolism in the era of direct oral anticoagulants.
    Kaneda K; Yamashita Y; Morimoto T; Chatani R; Nishimoto Y; Ikeda N; Kobayashi Y; Ikeda S; Kim K; Inoko M; Takase T; Tsuji S; Oi M; Takada T; Otsui K; Kimura T;
    Eur J Intern Med; 2023 Dec; 118():59-72. PubMed ID: 37574348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive ability of modified Ottawa score for recurrence in patients with cancer-associated venous thromboembolism: From the COMMAND VTE Registry.
    Nishimoto Y; Yamashita Y; Morimoto T; Saga S; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Sato Y; Kimura T;
    Thromb Res; 2020 Jul; 191():66-75. PubMed ID: 32402995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of recurrence and bleeding events with mortality after venous thromboembolism: From the COMMAND VTE Registry.
    Yamashita Y; Yoshikawa Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Kimura T;
    Int J Cardiol; 2019 Oct; 292():198-204. PubMed ID: 31239211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer.
    Akl EA; Kahale L; Barba M; Neumann I; Labedi N; Terrenato I; Sperati F; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2014 Jul; (7):CD006650. PubMed ID: 25004410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism.
    Vedovati MC; Giustozzi M; Munoz A; Bertoletti L; Cohen AT; Klok FA; Connors JM; Bauersachs R; Brenner B; Campanini M; Becattini C; Agnelli G
    Eur J Intern Med; 2023 Jun; 112():29-36. PubMed ID: 36774305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes.
    Shaw JR; Douketis J; Le Gal G; Carrier M
    J Thromb Haemost; 2019 Jul; 17(7):1171-1178. PubMed ID: 31038838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival Implications of Thrombus Recurrence or Bleeding in Cancer Patients Receiving Anticoagulation for Venous Thromboembolism Treatment.
    McBane Ii RD; Vlazny DT; Houghton D; Casanegra AI; Froehling D; Daniels P; Riaz IB; Hodge DO; Wysokinski WE
    Thromb Haemost; 2023 May; 123(5):535-544. PubMed ID: 36574777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal dysfunction and long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE Registry.
    Tsuyuki Y; Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Kobayashi Y; Ono K; Aoyama T; Kimura T;
    Thromb Res; 2020 Mar; 187():39-47. PubMed ID: 31951937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism.
    Lecumberri R; Alfonso A; Jiménez D; Fernández Capitán C; Prandoni P; Wells PS; Vidal G; Barillari G; Monreal M;
    Thromb Haemost; 2013 Oct; 110(4):834-43. PubMed ID: 23846721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.